BSE Mid-Cap Index Rises 0.63%, Led by Emcure Pharma's 4.65% Gain

Nov 17 2025 10:00 AM IST
share
Share Via
The midcap segment of the BSE has demonstrated resilience, currently up 0.63% and gaining 0.71% over the past five days. This trend indicates strong investor interest despite market fluctuations. Emcure Pharma stands out with a notable return of 4.65%, while Ipca Labs has struggled, declining by 3.28%. The positive market sentiment is further supported by an advance-decline ratio of 3.93x, with 114 advancing stocks compared to 29 declining ones, highlighting the midcap sector as an attractive area for growth-focused investors.
The midcap segment of the BSE has shown notable resilience, with a current increase of 0.63%. Over the past five days, this segment has further strengthened, rising by 0.71%. This upward trend highlights the midcap stocks' ability to attract investor interest amid fluctuating market conditions.

Leading the pack is Emcure Pharma, which has delivered an impressive return of 4.65%, positioning it as the standout performer in the midcap category. Conversely, Ipca Labs has faced challenges, recording a decline of 3.28%, marking it as the worst performer within this segment.

The overall market sentiment in the midcap space appears positive, as evidenced by the advance-decline ratio, which stands at 3.93x. This indicates that 114 stocks are advancing compared to 29 stocks that are declining, reflecting a robust interest in midcap equities. As the market continues to evolve, the midcap segment remains a focal point for investors seeking growth opportunities.

Mojo Stocks - The Top 1% Picks across Markets

Top 10 Large Cap Mid Cap Small Cap
{{col.header}}
Latest
OPEN CALL
CLOSED CALL
{{s[col.key]}} {{s.change_value}}
{{ s.score.value }} - {{ s.score.call_type }}
{{ s.dot_summary.score }} - {{ s.dot_summary.scoreText }}
{{s[col.key]}} {{col.extra}}

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News